Apotex, Ranbaxy End Pay-For-Delay Suit Over Narcolepsy Med
A Pennsylvania federal judge on Friday ended Canadian pharmaceutical company Apotex's pay-for-delay suit accusing generic-drug maker Ranbaxy of violating antitrust laws by accepting a settlement with Cephalon that improperly delayed generic...To view the full article, register now.
Already a subscriber? Click here to view full article